Literature DB >> 8945623

Cellular responses of HPV-positive cancer cells to genotoxic anti-cancer agents: repression of E6/E7-oncogene expression and induction of apoptosis.

K Butz1, C Geisen, A Ullmann, D Spitkovsky, F Hoppe-Seyler.   

Abstract

The E6 gene of tumor-associated types of human papillomaviruses codes for a functional antagonist of p53. Overexpression of E6 from heterologous promoters can block p53-mediated cellular responses to DNA damage, such as transcriptional stimulation of p53 target genes and cell-cycle arrest in G1. In contrast, genotoxic treatment of HPV-positive cancer cells, which express the E6 gene from chromosomally integrated viral copies, results in increased expression of the p53 target gene p21WAF1 and, in several cell lines, induction of G1 arrest. In the present study, we show that treatment with genotoxic agents, such as mitomycin C and cisplatin, leads to strong repression of viral E6/E7 oncogene expression in HPV16- and HPV18-positive cervical carcinoma cell lines. Kinetic analyses revealed that reduction of E6/E7 expression was not a prerequisite for induction of p21WAF1. We furthermore found that the apoptosis-promoting bax gene could be induced by genotoxic stress in some, but not all, HPV-positive cancer cell lines. Treatment with DNA-damaging agents eventually resulted in apoptotic cell death of HPV-positive cancer cells, irrespective of their capacity to induce the p53 target gene bax. These results support the notion that HPV-positive cancer cells can exhibit intact cellular responses to genotoxic stress, which may involve p53-dependent and -independent biochemical pathways. The ability of HPV-positive cancer cells to induce apoptotic cell death in response to DNA damage could provide a molecular explanation for the therapeutic effects of genotoxic agents in the treatment of cervical cancer.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8945623     DOI: 10.1002/(SICI)1097-0215(19961115)68:4<506::AID-IJC17>3.0.CO;2-2

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  24 in total

Review 1.  HPV-associated head and neck cancer: a virus-related cancer epidemic.

Authors:  Shanthi Marur; Gypsyamber D'Souza; William H Westra; Arlene A Forastiere
Journal:  Lancet Oncol       Date:  2010-05-05       Impact factor: 41.316

2.  Genus beta human papillomavirus E6 proteins vary in their effects on the transactivation of p53 target genes.

Authors:  Elizabeth A White; Johanna Walther; Hassan Javanbakht; Peter M Howley
Journal:  J Virol       Date:  2014-05-21       Impact factor: 5.103

3.  Increased sensitivity of HPV-positive head and neck cancer cell lines to x-irradiation ± Cisplatin due to decreased expression of E6 and E7 oncoproteins and enhanced apoptosis.

Authors:  Frank Ziemann; Andrea Arenz; Stefanie Preising; Claus Wittekindt; Jens P Klussmann; Rita Engenhart-Cabillic; Andrea Wittig
Journal:  Am J Cancer Res       Date:  2015-02-15       Impact factor: 6.166

Review 4.  Human Papilloma Virus (HPV) in head and neck region: review of literature.

Authors:  L Mannarini; V Kratochvil; L Calabrese; L Gomes Silva; P Morbini; J Betka; M Benazzo
Journal:  Acta Otorhinolaryngol Ital       Date:  2009-06       Impact factor: 2.124

Review 5.  Human papillomavirus and head and neck squamous cell carcinoma: recent evidence and clinical implications.

Authors:  P T Hennessey; W H Westra; J A Califano
Journal:  J Dent Res       Date:  2009-04       Impact factor: 6.116

6.  HPV-16 E6 L83V variant in squamous cell carcinomas of the upper aerodigestive tract.

Authors:  Paolo Boscolo-Rizzo; Maria Cristina Da Mosto; Roberto Fuson; Helena Frayle-Salamanca; Rossana Trevisan; Annarosa Del Mistro
Journal:  J Cancer Res Clin Oncol       Date:  2008-10-08       Impact factor: 4.553

7.  Treatment-related outcome of oropharyngeal cancer patients differentiated by HPV dictated risk profile: a tertiary cancer centre series analysis.

Authors:  P Bossi; E Orlandi; R Miceli; F Perrone; M Guzzo; L Mariani; R Granata; L Locati; C Fallai; B Cortelazzi; S Pilotti; G Scaramellini; A Gloghini; L Licitra
Journal:  Ann Oncol       Date:  2014-02-07       Impact factor: 32.976

Review 8.  Impact of human papillomavirus on oropharyngeal cancer biology and response to therapy: implications for treatment.

Authors:  Juliana Bonilla-Velez; Edmund A Mroz; Rebecca J Hammon; James W Rocco
Journal:  Otolaryngol Clin North Am       Date:  2013-06-27       Impact factor: 3.346

Review 9.  Molecular Aspects of Head and Neck Cancer Therapy.

Authors:  Sidharth V Puram; James W Rocco
Journal:  Hematol Oncol Clin North Am       Date:  2015-10-17       Impact factor: 3.722

10.  Human papilloma virus and survival of oropharyngeal cancer patients treated with surgery and adjuvant radiotherapy.

Authors:  Martina A Broglie; Alex Soltermann; Sarah R Haile; Gerhard F Huber; Sandro J Stoeckli
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-06-01       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.